Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

Musk has been an advocate for the widespread use of GLP-1 inhibitors to combat obesity. His stance has sparked debates, such ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and scientific acclamation. There are now ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Elon Musk's Christmas post has taken social media by storm! Dressed as a slimmer Santa, Musk's weight-loss transformation has ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...